ProShare Advisors’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $187K | Buy |
26,021
+1,020
| +4% | +$7.32K | ﹤0.01% | 1739 |
|
|
2025
Q1 | $150K | Sell |
25,001
-6,073
| -20% | -$36.4K | ﹤0.01% | 1760 |
|
|
2024
Q4 | $242K | Buy |
31,074
+7,267
| +31% | +$56.7K | ﹤0.01% | 1786 |
|
|
2024
Q3 | $257K | Buy |
23,807
+6,779
| +40% | +$73.2K | ﹤0.01% | 1571 |
|
|
2024
Q2 | $144K | Sell |
17,028
-5,178
| -23% | -$43.7K | ﹤0.01% | 1601 |
|
|
2024
Q1 | $149K | Buy |
22,206
+2,953
| +15% | +$19.8K | ﹤0.01% | 1746 |
|
|
2023
Q4 | $113K | Buy |
19,253
+3,130
| +19% | +$18.4K | ﹤0.01% | 1761 |
|
|
2023
Q3 | $157K | Buy |
16,123
+2,565
| +19% | +$25K | ﹤0.01% | 1538 |
|
|
2023
Q2 | $161K | Buy |
13,558
+1,179
| +10% | +$14K | ﹤0.01% | 1594 |
|
|
2023
Q1 | $134K | Sell |
12,379
-1,639
| -12% | -$17.7K | ﹤0.01% | 1534 |
|
|
2022
Q4 | $162K | Buy |
14,018
+1,430
| +11% | +$16.5K | ﹤0.01% | 1547 |
|
|
2022
Q3 | $188K | Buy |
+12,588
| New | +$188K | ﹤0.01% | 1425 |
|
|
2022
Q2 | – | Sell |
-11,101
| Closed | -$83K | – | 1850 |
|
|
2022
Q1 | $83K | Sell |
11,101
-2,633
| -19% | -$19.7K | ﹤0.01% | 2064 |
|
|
2021
Q4 | $118K | Buy |
+13,734
| New | +$118K | ﹤0.01% | 2170 |
|
|
2019
Q3 | – | Sell |
-2,708
| Closed | -$28K | – | 1663 |
|
|
2019
Q2 | $28K | Sell |
2,708
-362
| -12% | -$3.74K | ﹤0.01% | 1597 |
|
|
2019
Q1 | $54K | Buy |
3,070
+32
| +1% | +$563 | ﹤0.01% | 1611 |
|
|
2018
Q4 | $53K | Buy |
+3,038
| New | +$53K | ﹤0.01% | 1521 |
|